Training Data

Carl Eschenbach, CEO of Workday and former Sequoia partner, shares insights on evolving workplace dynamics as AI becomes integral to operations. He discusses a three-pronged monetization strategy for AI, emphasizing domain-specific agents over general models. Eschenbach highlights the importance of a collaborative environment between human workers and AI, assuring that job displacement fears can be mitigated. He also touches on innovative recruitment strategies powered by AI, advocating for a skills-based approach while preserving human judgment.

Max Jaderberg, Chief AI Officer of Isomorphic Labs and former DeepMind pioneer, discusses revolutionary advancements in drug discovery with AI. He highlights AlphaFold 3's potential to redefine molecular understanding and predicts we are nearing a 'Move 37 moment', where AI can surpass human intuition in drug design. Jaderberg envisions general AI capable of solving all diseases, emphasizing the need for innovative agents to navigate the vast potential of molecular designs, revolutionizing both biology and pharmacology.

Manny Medina, former Outreach CEO and founder of Paid, shares insights on pricing for AI companies with a focus on unit economics. He argues that traditional SaaS models fail in the AI realm, advocating for outcome-based and agent-based pricing strategies. Manny emphasizes the success of niche AI applications over broad platforms and discusses the critical need for AI firms to refine their understanding of profitability. He also highlights the importance of quality customer focus and innovative company culture in driving growth.

Patrick Hsu, co-founder of Arc Institute and a pioneer in genome editing and CRISPR technologies, shares insights on merging AI with biology. He discusses Evo 2, a groundbreaking model that analyzes genomic data to identify disease-causing mutations and design new biological systems. Patrick highlights the transformative potential of AI in drug discovery, emphasizing collaboration between academia and industry. He also explores the gut-brain connection and advocates for holistic health approaches, illustrating how AI can personalize medicine and enhance wellness.

Amjad Masad, the CEO and founder of Replit, a platform empowering a billion software creators, dives into his vision of accessible programming for all. He discusses how LLMs could revolutionize the developer landscape, enhancing productivity and social impact. Masad shares his journey from programming in Jordan to leading a tech company in Silicon Valley. He also reflects on the delicate balance of innovative management and the importance of diverse talent in tech. The conversation touches on the optimistic potential of AI, emphasizing empowerment over replacement.

Christopher O’Donnell, Founder of Day.ai and former Chief Product Officer at HubSpot, discusses the transformative power of AI in CRM. He shares insights on overcoming common CRM issues like data silos and complex workflows. O’Donnell explains how Day.ai's approach captures customer context effortlessly, enhancing user engagement. He reflects on building HubSpot’s CRM, emphasizing the need for a careful, quality-focused development process. The conversation highlights revolutionary strategies and the ethical considerations in AI-driven product evolution.

Filip Kozera, co-founder of Wordware, inspires a new generation of 'word artisans' by bridging human creativity and AI development. He draws fascinating parallels between Excel's democratization of data analytics and Wordware's mission. The discussion dives into using natural language as a programming tool, emphasizing effective communication to enhance AI control. Filip envisions a future where unstructured data fosters creativity, and tools like Lovable and Gemini enhance productivity. Excitingly, he hints at innovations like the Limitless pendant for personalized AI experiences.

Josh Woodward, VP of Google Labs, leads teams at the forefront of AI innovation. He discusses the rapid development of tools, with AI now writing 25% of Google’s code. Woodward emphasizes the need for taste and design in AI products and the importance of evolving coding practices this year. Key topics include transforming video generation through models like Veo 2, exploring human-computer interaction with Project Mariner, and the optimistic future where costs of AI solutions will dramatically decrease, enhancing creativity and productivity.

Winston Weinberg, Co-founder and CEO of Harvey, brings his expertise in legal AI to the forefront. He discusses the necessity of deep process knowledge for success in legal tech, beyond just powerful models. Weinberg details how Harvey fosters trust with law firms through tailored demos and focuses on complex tasks like international mergers. The conversation dives into the role of AI in reshaping legal practices, enhancing access to services, and the urgent need for innovation in the industry.

Daniel Nadler, CEO and co-founder of OpenEvidence, discusses his revolutionary AI-powered medical knowledge platform designed to aid doctors in real-time. He highlights how smaller, specialized AI models can outperform larger ones in healthcare applications. The conversation covers the app's rapid adoption—growing from 1,000 to over 100,000 users in a year—and its role in democratizing access to medical information. Nadler also emphasizes the significance of accurate, transparent AI in healthcare, and the beneficial partnerships with publishers to improve patient outcomes.